Cargando…
Live Vaccination with Blood-Stage Plasmodium yoelii 17XNL Prevents the Development of Experimental Cerebral Malaria
In our work, we aim to develop a malaria vaccine with cross-strain (-species) protection. C57BL/6 mice infected with the P. berghei ANKA strain (PbA) develop experimental cerebral malaria (ECM). In contrast, ECM development is inhibited in infected mice depleted of T cells. The clinical applications...
Autores principales: | Imai, Takashi, Ngo-Thanh, Ha, Suzue, Kazutomo, Shimo, Aoi, Nakamura, Akihiro, Horiuchi, Yutaka, Hisaeda, Hajime, Murakami, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145751/ https://www.ncbi.nlm.nih.gov/pubmed/35632518 http://dx.doi.org/10.3390/vaccines10050762 |
Ejemplares similares
-
Long-Read Genome Assembly and Gene Model Annotations for the Rodent Malaria Parasite Plasmodium yoelii 17XNL
por: Godin, Mitchell J., et al.
Publicado: (2023) -
Long-read genome assembly and gene model annotations for the rodent malaria parasite Plasmodium yoelii 17XNL
por: Godin, Mitchell J., et al.
Publicado: (2023) -
Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria Plasmodium yoelii
por: Imai, Takashi, et al.
Publicado: (2019) -
Potential and Limitations of Cross-Protective Vaccine against Malaria by Blood-Stage Naturally Attenuated Parasite
por: Imai, Takashi, et al.
Publicado: (2020) -
Nonobese Diabetic (NOD) Mice Lack a Protective B-Cell Response against the “Nonlethal” Plasmodium yoelii 17XNL Malaria Protozoan
por: Mendoza, Mirian, et al.
Publicado: (2016)